Zentalis Pharmaceuticals, Inc. Common Stock — Institutional Ownership

Which tracked institutions hold ZNTL, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.

14
Funds holding
$11860541
Total value held
Buying
9 added/new · 4 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $2971419 1269837 +19869 +1.59%
2 Bank Of America Corp /De/ $2649568 1132294 -234960 -17.18%
3 Barclays Plc $1383448 591217 NEW BUY
4 Pfizer Inc $1287675 953834 Held
5 Goldman Sachs Group Inc $1082666 462678 +344466 +291.40%
6 Morgan Stanley $819483 350207 -453447 -56.42%
7 State Street Corp $584275 249690 -22100 -8.13%
8 Sei Investments Co $448229 191551 NEW BUY
9 Northern Trust Corp $276555 118186 +25315 +27.26%
10 Invesco Ltd. $254586 188582 +14961 +8.62%
11 Raymond James Financial Inc $53574 22895 +3000 +15.08%
12 Prudential Financial Inc $48789 20850 -3700 -15.07%
13 Amalgamated Financial Corp. $274 5945 NEW BUY
14 Royal Bank Of Canada $0 98 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.